These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9853453)

  • 21. [An update on Interleukin-2 in HIV-infection].
    Héripret L; Beumont-Mauviel M
    Med Mal Infect; 2005 Jun; 35 Suppl 2():S33-4. PubMed ID: 15978380
    [No Abstract]   [Full Text] [Related]  

  • 22. Combining CD4 recovery and CD4: CD8 ratio restoration as an indicator for evaluating the outcome of continued antiretroviral therapy: an observational cohort study.
    Lee SS; Wong NS; Wong BCK; Wong KH; Chan KCW
    BMJ Open; 2017 Sep; 7(9):e016886. PubMed ID: 28918411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.
    Kaufmann GR; Zaunders J; Cooper DA
    Sex Transm Infect; 1999 Aug; 75(4):218-24. PubMed ID: 10615305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy.
    Sriram U; Wong M; Caillier SJ; Hecht FM; Elkins MK; Levy JA; Oksenberg JR; Baranzini SE
    AIDS Res Hum Retroviruses; 2007 May; 23(5):741-7. PubMed ID: 17531001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and strategies for the eradication of the HIV reservoir.
    Kimata JT; Rice AP; Wang J
    Curr Opin Immunol; 2016 Oct; 42():65-70. PubMed ID: 27288651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
    Marchetti G; Meroni L; Varchetta S; Terzieva V; Bandera A; Manganaro D; Molteni C; Trabattoni D; Fossati S; Clerici M; Galli M; Moroni M; Franzetti F; Gori A
    J Infect Dis; 2002 Sep; 186(5):606-16. PubMed ID: 12195347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features.
    Fogli M; Iaria M; Focá E; Giagulli C; Caccuri F; Maggi F; Torti C; Caruso A; Fiorentini S
    New Microbiol; 2014 Jan; 37(1):75-80. PubMed ID: 24531173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
    Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 and immune control: can we change the course of HIV-1?
    Kovacs A; Connors M
    Lancet; 2004 Mar; 363(9412):833-4. PubMed ID: 15031022
    [No Abstract]   [Full Text] [Related]  

  • 30. Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapy.
    Winston A; Jose S; Fisher M; Walsh J; Nelson M; Gilson R; Post F; Johnson M; Leen C; Chadwick D; Hay P; Pritchard J; Tariq A; Sabin C;
    J Allergy Clin Immunol; 2015 Dec; 136(6):1682-1685.e1. PubMed ID: 26253341
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.
    De Paoli P
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):671-7. PubMed ID: 11427409
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.
    Chun TW; Engel D; Mizell SB; Hallahan CW; Fischette M; Park S; Davey RT; Dybul M; Kovacs JA; Metcalf JA; Mican JM; Berrey MM; Corey L; Lane HC; Fauci AS
    Nat Med; 1999 Jun; 5(6):651-5. PubMed ID: 10371503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE).
    Avettand-Fenoel V; Bouteloup V; Mélard A; Fagard C; Chaix ML; Leclercq P; Chêne G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2010 Oct; 65(10):2212-4. PubMed ID: 20667886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tale of two trials of HAART interruption.
    STEP Perspect; 1999; 99(1):7. PubMed ID: 11367165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy as an adjunct to highly-active antiretroviral therapy.
    Murphey-Corb M; Heydenburg-Fuller D
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1191-7. PubMed ID: 11717803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy.
    Peters BS; Samuel M
    J HIV Ther; 2010 Mar; 15(1):15-7. PubMed ID: 21180234
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player.
    Khoury G; Rajasuriar R; Cameron PU; Lewin SR
    Clin Immunol; 2011 Dec; 141(3):253-67. PubMed ID: 21996455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment.
    David D; Naït-Ighil L; Dupont B; Maral J; Gachot B; Thèze J
    J Infect Dis; 2001 Mar; 183(5):730-5. PubMed ID: 11181149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.